Rawan S Bafail

Title: Rawan S Bafail: Innovator in Pharmaceutical Formulations

Introduction

Rawan S Bafail is a notable inventor based in Sharjah, United Arab Emirates. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of rapidly-disintegrating sublingual tablets. Her work focuses on improving therapeutic options for patients exposed to organophosphate toxicity.

Latest Patents

Rawan S Bafail holds a patent for a formulation of atropine sulfate rapidly-disintegrating sublingual tablets. This invention provides an improved formulation in a sublingual dosage form, offering an alternative and easy-to-use method for managing organophosphate toxicity. The patent outlines methods for the therapeutic use of these tablets, enhancing the quality evaluation and formulation processes.

Career Highlights

She is currently affiliated with the University of Sharjah, where she continues her research and development in pharmaceutical sciences. Her innovative approach has garnered attention in the academic and medical communities, contributing to advancements in treatment methodologies.

Collaborations

Rawan collaborates with her coworker, Mutasem Rawas-Qalaji, who is also involved in research and development within the same field. Their partnership enhances the scope and impact of their work, fostering a collaborative environment for innovation.

Conclusion

Rawan S Bafail's contributions to the field of pharmaceutical formulations exemplify her commitment to improving healthcare solutions. Her innovative work in developing rapidly-disintegrating sublingual tablets represents a significant advancement in the treatment of organophosphate toxicity.